Reviva Pharmaceuticals Holdings Inc. (RVPH) — Financial Flexibility Index

Latest as of December 2025: -3.38x

Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Financial Flexibility Index of -3.38x as of December 2025. Free cash flow of $-24.59 Trillion (operating CF $-24.59 Trillion minus capex $4.00) represents -3% of total liabilities ($7.28 Trillion). Also explore RVPH year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-3.38x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-24.59 Trillion
Operating CF − Capex

Total Liabilities

$7.28 Trillion
USD

Capital Expenditures

$4.00
USD

Reviva Pharmaceuticals Holdings Inc. Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for Reviva Pharmaceuticals Holdings Inc. across 8 annual periods. Check RVPH capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Reviva Pharmaceuticals Holdings Inc. (2018–2025)

Year-by-year free cash flow to debt coverage for Reviva Pharmaceuticals Holdings Inc.. For the full company profile including market capitalisation, see RVPH company net worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -3.38x $-24.59 Trillion $-24.59 Trillion $7.28 Trillion ▼ -48.0%
2024 -2.28x $-33.54 Million $-33.54 Million $14.69 Million ▼ -45.0%
2023 -1.58x $-28.32 Million $-28.32 Million $17.98 Million ▲ +12.5%
2022 -1.80x $-18.96 Million $-18.96 Million $10.53 Million ▲ +54.1%
2021 -3.93x $-10.67 Million $-10.67 Million $2.72 Million ▼ -218.2%
2020 -1.23x $-4.07 Million $-4.07 Million $3.30 Million ▼ -3748.1%
2019 -0.03x $-218.44K $-218.44K $6.81 Million ▲ +81.8%
2018 -0.18x $-1.07 Million $-1.07 Million $6.09 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities